miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Boye Schnack,Nielsen ^[1] ; Eva,Balslev ^[2] ; Tim Svenstrup,Poulsen ^[2] ; Dorte,Nielsen ^[3] ; Trine,Møller ^[1] ; Christiane Ehlers,Mortensen ^[3] ; Kim,Holmstrøm ^[1] ; Estrid,Høgdall ^[2]

作者单位： Bioneer A/S , Hørsholm , Denmark. ^[1] Department of Pathology, Herlev Hospital, University of Copenhagen , Herlev , Denmark. ^[2] Department of Oncology, Herlev Hospital, University of Copenhagen , Herlev , Denmark. ^[3]

关键词 HER2 biomarker breast cancer miR-21 prediction response trastuzumab

DOI 10.3389/fonc.2014.00207

PMID 25177545

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览66

Frontiers in oncology

2014年4卷

207页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除